The trading price of Tevogen Bio Holdings Inc (NASDAQ:TVGN) closed higher on Monday, May 05, and closing at $1.06, 4.95% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.09 and a 52-week low of $0.26. Over the past month, the stock has gained 6.00% in value.
Tevogen Bio Holdings Inc, whose market valuation is $194.93 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest TVGN has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
A quick review shows that TVGN’s price is currently 4.75% off the SMA20 and -3.60% off the SMA50. The RSI metric on the 14-day chart is currently showing 51.32, and weekly volatility stands at 11.68%. When measured over the past 30 days, the indicator reaches 10.83%. Tevogen Bio Holdings Inc (NASDAQ:TVGN)’s beta value is currently sitting at -0.80, while the Average True Range indicator is currently displaying 0.10.
To see how Tevogen Bio Holdings Inc stock has been performing in comparison to its peers in the industry, here are the numbers: TVGN stock’s performance was 4.95% in the latest trading, and 9.28% in the past year.
An evaluation of the daily trading volume of Tevogen Bio Holdings Inc (NASDAQ:TVGN) indicates that the 3-month average is 947.22K.
Currently, records show that 177.99 million of the company’s shares remain outstanding. The insiders hold 85.39% of outstanding shares, whereasinstitutions hold 1.44%. However, since the stock’s price has seen 2.91% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
